Buy or sell guide
Should I Buy ISRG Stock Right Now?
A fast read on Wall Street conviction, live analyst commentary on X, and current valuation context for Intuitive Surgical, Inc..
Updated 2026-05-07
Wall Street currently rates ISRG buy with a 12-month price target of $623 (+37.8% upside). The sections below cover the bull case, key risks, and latest earnings context for ISRG.
Wall Street
Buy55 analystsConsensus target
$623 target (+37.8%)Current price $451.73Analyst sentiment
No recent analyst posts capturedWaiting for fresh postsEarnings context
EPS beat 17.9%Reported Tue Apr 21Wall Street verdict
Should I Buy ISRG Stock? Here's What Analysts Think
55 analysts currently cover ISRG. Below is their consensus rating, price target range, and implied upside.
According to 55 analysts, Intuitive Surgical, Inc. (ISRG) is rated Buy with a consensus 12-month price target of $623 — representing 38% upside from today's price of $452. The bull case target is $750, the bear case is $525.
ISRGBuy
From 55 analyst ratings- Current price
- $451.73
- Consensus Target
- $623 (+37.8% upside)
- Forward P/E
- 43.7x
- Coverage
- 55 analyst ratings
High target$750
Low target$525
At $451.73, the consensus setup implies +37.8% versus the 12-month target.
- 38 of 55 analysts lean Buy or Strong Buy, while 12 stay on Hold and 5 lean bearish.
- ISRG trades at roughly 43.7x forward earnings, so the bull case still depends on growth staying strong.
- Analysts span a wide range from $525 to $750, so conviction matters as much as the consensus target.
Below, compare that institutional answer with the live analyst commentary on X for ISRG right now.
7 of 10 analysts cut targetsBarclays $651Leerink Partners $573Baird $610+5 more
May 2026Live commentary on X
What Analysts Are Saying About Intuitive Surgical, Inc. Right Now
Real posts from high-reach stock analysts mentioning ISRG, shown exactly as written. Sorted by engagement — most discussed first.
No recent posts captured
No high-reach analysts have posted about ISRG in the last 7 days. Check back after the next earnings release or market-moving event.
Should you buy ISRG?
Is ISRG a Buy, Hold, or Sell Right Now?
A structured look at the bull case, the risks, and the most recent earnings execution for ISRG before you decide whether to buy, hold, or sell.
Current setup
ISRG beat estimates last quarter. Below are the key reasons analysts remain constructive and the risks that could change that view.
Bull Case
What keeps the long thesis intact
- Strong Buy ConsensusAnalysts have a consensus rating of 'Strong Buy' with a median price target of $580.00, indicating a potential upside of 27.8%.
- Robust Procedure GrowthManagement raised the 2026 procedure growth outlook to 13.5%-15.5%, supported by increased utilization across platforms.
- High Recurring RevenueApproximately 75% of ISRG's revenue comes from recurring sources, providing a stable and high-margin revenue stream.
- Market Leadership PositionISRG maintains a dominant position in the robotic surgery market with a substantial installed base of da Vinci systems.
- Innovation and ExpansionContinued innovation and expansion into international markets strengthen ISRG's competitive position.
- Strong Financial PerformanceISRG has consistently beaten EPS estimates and shown increasing operating income.
Wall Street rates ISRG buy, giving the bull case institutional backing from 55 analysts.
Watch Out For
What can break the setup quickly
- High Valuation ConcernsISRG trades at a high P/E ratio of around 55-58, with some analysts suggesting it could be overvalued by 30.2%.
- Decelerating Procedure GrowthProcedure growth is projected to slow to 13.5%-15.5% in 2026, down from 18% in 2025.
- External Revenue PressuresFactors like tariffs and pricing pressures in China could negatively impact revenue.
- Increasing Competition RisksGrowing competition in the medical technology industry may compress valuation multiples.
- Converging Utilization RatesUtilization rates for the SP and Ion systems are converging, potentially limiting future growth.
- Insider Selling ActivityThere has been net selling by insiders, although largely tied to vesting schedules.
Watch whether new negative commentary on ISRG points to these structural risks or is simply reacting to short-term price moves.
ISRG Earnings Reaction — What the Last Quarter Showed
Last Quarter
- EPS
- $2.50 vs $2.12 est.Beat 17.9%
- Revenue
- $2.8B vs $2.6B est.Beat 5.8%
Full ISRG Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy ISRG Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See ISRG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ISRG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare with Peers
Compare business quality, growth, and profitability against top sector peers.
Start ComparisonISRG — Frequently Asked Questions
Quick answers to the most common questions about buying ISRG stock.
Should I buy ISRG stock right now?
Verdict
ISRG looks attractive at current levels — Wall Street's consensus rating is "Buy" with a $623 price target (+37.8% upside from $451.73). This is informational only — verify the data and consider your own risk tolerance before deciding.
Is now a good time to buy ISRG?
Timing
Timing depends on your horizon, but the data signals are: consensus rating "Buy" with +37.8% upside to the $623 target. In the past 30 days, 7 of 10 covering analysts cut their price targets — a bearish signal.
What is the price target for ISRG stock?
Price Target
ISRG's consensus 12-month price target is $623, set by 55 Wall Street analysts. The bull case high is $750 and the bear case low is $525. From the current price of $451.73, this implies +37.8% upside.
Is ISRG overvalued or undervalued?
Valuation
ISRG appears undervalued — the $623 consensus target is +37.8% above today's $451.73. It trades at a forward P/E of 43.7x. Targets range from $525 (bear) to $750 (bull), reflecting different assumptions about growth and margins.
Should I buy ISRG before earnings?
Earnings
ISRG reports next quarter. Earnings-week moves are volatile — historically, analyst targets revise upward after a beat and downward after a miss. The current consensus is "Buy" with a $623 target. Consider position sizing rather than going all-in pre-print.
What are analysts saying about ISRG stock?
Coverage
Of 55 analysts covering Intuitive Surgical, Inc. (ISRG): 0 Strong Buy, 38 Buy, 12 Hold, 5 Sell, 0 Strong Sell — a "Buy" consensus. The 12-month price target is $623 (range $525–$750). Bullish analysts outnumber bearish by more than 2-to-1.
What are the risks of buying ISRG stock?
Risks
5 of the 55 analysts covering ISRG rate it Sell or Strong Sell. Common concerns include valuation stretch, slowing growth, and sector-specific headwinds — see the Bull vs. Risk cards above for the specific theses on Intuitive Surgical, Inc..
This page is for informational purposes only and does not constitute financial advice. Always conduct your own research before investing.